Two new studies appear to strengthen the science indicating Zantac’s active ingredient, ranitidine, converts to the cancer-causing chemical NDMA duriing digestive processes.…
Plaintiffs involved in 41 federal Zantac lawsuits say their cases were wrongly removed to federal court, and are asking the Zantac MDL judge to remand their cases back to California state courts where they originated.…
Plaintiffs say they plan to show how numerous types of cancer are linked to the side effects of Zantac, which has been recalled due to high levels of the toxic chemical, NDMA.…
Zantac lawsuits filed against generic manufacturers, renovators and retailers have been dismissed by a federal judge, leaving only brand-name manufacturers to face claims the recalled heartburn drug can cause cancer.…
A new study links NDMA found in Zantac to a higher risk of gastrointestinal cancers than other heartburn drugs.…
A new study reports to have found how Zantac changes into NDMA, which has been linked to an increased risk of cancer.…
NDMA appears to be an inherent side effect of Zantac chemical interactions, meaning the cancer-causing chemicals have been in the popular heartburn drug since it was first put on the market.…
A Zantac lawsuit claims the side effects of the recalled drug resulted in gallbladder damage and a stomach cancer diagnosis for a man who used over-the-counter formulations for two years.…
Zantac lawsuits continue to be filed as more former users learn the heartburn drug they used for years may have caused them to develop cancer.…
Plaintiffs are defending their right to file Zantac lawsuits in the face of an attempt by generic manufacturers and repackagers to have cases not involving actual claims of cancer dismissed.…
